Scorpion Biological Services

Activities: Drug Delivery

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Beyond capacity: biopharma companies need agile manufacturing partners To succeed in the biopharmaceutical industry, organisations require a future-focused lens. What is in the clinical pipeline? What will demand look like in 5 years? When are key...
  2. 25 years of Guardtech: the past, present and future as told by their founder The Suffolk contamination control specialists constructed their first ever cleanroom 25 years ago – Director and founder Ray Wheeler explains how Guardtech became the...
  3. CDMO Enteris BioPharma rebrands to MOD3 Pharma The name change reflects the company's refocusing on orally inhaled and nasal drug product (OINDP) manufacturing
  4. Merck opens $1bn US vaccine manufacturing centre in Durham, North Carolina The extension aligns with Merck's plant to expand its US pharmaceutical manufacturing footprint, with the company planning to invest another $8bn by 2028
  5. Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer Cellevate AB is pleased to announce the appointment of Dr. Christel Fenge as Chief Technology Officer (CTO) and member of the management team

Upcoming event

DCAT Week

17–20 March 2025 | Conference | New York, US See all

Related Content

Finance

Scorpion Biological Services becomes Scorpius BioManufacturing to reflect expansion

Scorpion Biological Services has changed its name to Scorpius BioManufacturing reflecting the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October
Drug Delivery

Scorpion opens new San Antonio facility for biologic drugs

The global pharmaceutical CDMO market is projected to reach $171 billion by 2026 from $120 billion in 2021
Subscribe now